Parkinson's Trial NCT07536490
Determine if sleep affects thinking
- Trial ID
- NCT07536490
- Official Title
- Investigation of the Relationship Between Sleep Quality, Cognitive Functions, and Disease Severity in Patients With Parkinson's Disease
- Goal
- Determine if sleep affects thinking
- Status
- COMPLETED
- Sponsor
- Ankara University
- Study Type
- OBSERVATIONAL
- Enrollment
- 75 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to see whether poorer sleep is linked with worse thinking skills and greater Parkinson's severity, to help clarify if sleep problems track with cognitive decline or disease progression. The team will observe and compare sleep quality measures with cognitive testing like the MoCA and clinical staging with the Hoehn and Yahr scale, they are not testing a drug or therapy but looking for patterns that could guide future treatments. The trial is enrolling people age 40 to 65 with neurologist-confirmed Parkinson's, Hoehn and Yahr stage 1 to 3 and MoCA scores of 21 or higher, and excludes those with major communication, visual, heart, or other neurologic conditions.
Locations
- Hacettepe University, Ankara, Ankara, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see whether poorer sleep is linked with worse thinking skills and greater Parkinson's severity, to help clarify if sleep problems track with cognitive decline or disease progression. The team will observe and compare sleep quality measures with cognitive testing like the MoCA and clinical staging with the Hoehn and Yahr scale, they are not testing a drug or therapy but looking for patterns that could guide future treatments. The trial is enrolling people age 40 to 65 with neurologist-confirmed Parkinson's, Hoehn and Yahr stage 1 to 3 and MoCA scores of 21 or higher, and excludes those with major communication, visual, heart, or other neurologic conditions.
- Who can participate?
- Participants must be between 40 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 month.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- How many visits does this trial involve?
- All assessments are completed during a single evaluation session.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Thinking & memory tests (non-invasive). Confirm the full schedule with the study coordinator.